Modeling the restricted mean survival time using pseudo-value random forests
利用伪值随机森林建模限制平均生存时间AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要明确包含混杂调整后的处理对比及 RMST 因果分析,因此归入因果推断。
利用伪值随机森林建模限制平均生存时间AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
The restricted mean survival time (RMST) has become a popular measure to summarize event times in longitudinal studies. Defined as the area under the survival function up to a time horizon $τ$ > 0, the RMST can be interpreted as the life expectancy within the time interval [0, $τ$]. In addition to its straightforward interpretation, the RMST also allows for the definition of valid estimands for the causal analysis of treatment contrasts in medical studies. In this work, we introduce a non-parametric approach to model the RMST conditional on a set of baseline variables (including, e.g., treatment variables and confounders). Our method is based on a direct modeling strategy for the RMST, using leave-one-out jackknife pseudo-values within a random forest regression framework. In this way, it can be employed to obtain precise estimates of both patient-specific RMST values and confounder-adjusted treatment contrasts. Since our method (termed "pseudo-value random forest", PVRF) is model-free, RMST estimates are not affected by restrictive assumptions like the proportional hazards assumption. Particularly, PVRF offers a high flexibility in detecting relevant covariate effects from higher-dimensional data, thereby expanding the range of existing pseudo-value modeling techniques for RMST estimation. We investigate the properties of our method using simulations and illustrate its use by an application to data from the SUCCESS-A breast cancer trial. Our numerical experiments demonstrate that PVRF yields accurate estimates of both patient-specific RMST values and RMST-based treatment contrasts.